Physician

Alissa Steele, PA-C

According to 2025 Medicare claims, Alissa Steele, PA-C (NPI: 1750833513) practices physician assistant in the Kankakee, IL market, with the plurality of this provider's patient population coming from Kankakee, IL. This provider's primary affiliated billing organization is VITALSKIN MEDICAL GROUP IL PLLC (NPI: 1417657321; TIN: 851790842) and primary practice location at 60914-5187.

Steele's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 287 traditional Medicare patients, billed 1,444 HCPCS/CPT codes, and received $41,701 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 510 prescription claims across 202 beneficiaries totaling $281,152 in drug costs, led by Rinvoq (Upadacitinib). DME data shows 11 claims. Open Payments data shows 139 records totaling $2,804. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $8,194 and ending at $41,701. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,313 and ending at $281,152. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	66	157	$8,194
2018	N/R	N/R	N/R
2019	192	654	$26,174
2020	235	772	$31,029
2021	242	739	$39,796
2022	155	260	$13,165
2023	241	1,175	$42,615
2024	287	1,444	$41,701

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	46	216	$4,313
2018	116	179	$3,809
2019	286	3,422	$310,516
2020	260	4,016	$382,787
2021	276	4,290	$401,264
2022	292	3,656	$332,371
2023	207	576	$97,040
2024	202	510	$281,152

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	37	$483
2020	31	134	$2,701
2021	11	61	$1,950
2022	N/R	50	$3,945
2023	N/R	24	$3,004
2024	N/R	11	$2,437

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	57	77	$68
11102	Biopsy of related skin growth, first growth	48	49	$55
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	146	168	$50
17000	Destruction of precancer skin growth, 1 growth	139	168	$36
17003	Destruction of precancer skin growth, 2-14 growths	104	548	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	11	330	$82,132
Dupixent Pen	Dupilumab	21	588	$78,236
Clobetasol Propionate	Clobetasol Propionate	60	1,907	$2,433
Econazole Nitrate	Econazole Nitrate	43	1,580	$1,890
Triamcinolone Acetonide	Triamcinolone Acetonide	110	3,798	$1,437

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$2,437

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	139	$2,804	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alissa Steele, PA-C?

Tedicare shows public-source Medicare data for Alissa Steele, PA-C (NPI 1750833513), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alissa Steele, PA-C have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alissa Steele, PA-C?

Alissa Steele, PA-C is linked to VITALSKIN MEDICAL GROUP IL PLLC (billing NPI 1417657321) in the available physician profile data.

Does Alissa Steele, PA-C have Open Payments data?

Alissa Steele, PA-C has 139 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.